Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 18 November 2005. doi:10.1136/gut.2005.083022
Gut 2006;55:616-618
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2005.083022v1
55/5/616    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raderer, M
Right arrow Articles by Chott, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raderer, M
Right arrow Articles by Chott, A
Topic Collections
Right arrowRelevant Article

STOMACH

Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas

M Raderer1, B Streubel2, S Wöhrer1, M Häfner3, A Chott1

1 Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria
2 Department of Pathology, Medical University of Vienna, Vienna, Austria
3 Department of Medicine IV, Division of Gastroenterology, Medical University of Vienna, Vienna, Austria

Correspondence to:
Correspondence to:
Dr M Raderer
Department of Medicine I, Division of Oncology, Medical University Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria; markus.raderer{at}meduniwien.ac.at

Background and aims: The role of antibiotic treatment in early stage gastric mucosa associated lymphoid tissue (MALT) lymphoma not associated with Helicobacter pylori infection has not been investigated.

Patients and methods: Six patients with localised gastric MALT lymphoma underwent antibiotic treatment with clarithromycin, metronidazole, and pantoprazole. Staging, including endosonography plus gastroscopy, computed tomography of the thorax and abdomen, colonoscopy, magnetic resonance imaging of the salivary glands, and bone marrow biopsy were performed to rule out distant spread of the disease. In addition, MALT specific genetic changes, including reverse transcriptase-polymerase chain reaction for t(11;18)(q21;q21), were tested in all patients. H pylori infection was ruled out by histology, urease breath test, serology, and stool antigen testing.

Results: All six patients had MALT lymphoma restricted to the stomach, and no evidence of infection with H pylori was found. Only one patient tested positive for t(11;18)(q21;q21) while the remaining five displayed no genetic aberrations. Following antibiotic treatment, endoscopic controls were performed every three months. Five patients responded with lymphoma regression between three and nine months following antibiotic treatment (one partial remission and four complete responses). One patient had stable disease for 12 months and was then referred for chemotherapy.

Conclusions: Patients with early stage gastric MALT lymphoma negative for H pylori might still benefit from antibiotic treatment as the sole treatment modality.


Abbreviations: MALT, mucosa associated lymphoid tissue; CT, computed tomography; CR, complete remission; PR, partial remission

Keywords: Helicobacter pylori; mucosa associated lymphoid tissue lymphoma; antibiotic treatment


Relevant Article

H pylori negative MALT lymphoma patients successfully treated with antibiotics: doubts about their H pylori negativity Author’s reply
E Lahner, M Milione, G Delle Fave, B Annibale, and M Raderer
Gut 2006 55: 1669. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology